Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Wave Life Sci Ord Sh
(NQ:
WVE
)
8.730
+0.120 (+1.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,394,610
Open
8.650
Bid (Size)
8.620 (5)
Ask (Size)
8.870 (1)
Prev. Close
8.610
Today's Range
8.545 - 8.920
52wk Range
3.510 - 9.920
Shares Outstanding
98,983,261
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
October 03, 2024
These two could become direct competitors relatively soon.
Via
The Motley Fool
Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 01, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Performance
YTD
+63.48%
+63.48%
1 Month
+45.99%
+45.99%
3 Month
+45.74%
+45.74%
6 Month
+52.09%
+52.09%
1 Year
+56.17%
+56.17%
More News
Read More
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
September 30, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (4 Ratings)
August 09, 2024
Via
Benzinga
What Analysts Are Saying About WAVE Life Sciences Stock
June 26, 2024
Via
Benzinga
Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
September 25, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
General Motors To $42? Here Are 10 Top Analyst Forecasts For Wednesday
September 25, 2024
Via
Benzinga
Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 25, 2024
Via
Benzinga
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
September 24, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Crude Oil Gains Over 1%; BioVie Shares Plunge
September 24, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Surges 100 Points; Thor Industries Earnings Top Views
September 24, 2024
Via
Benzinga
Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug
September 24, 2024
Via
Benzinga
Wave Life Sciences, Nio, Li Auto, Tesla And Other Big Stocks Moving Higher On Tuesday
September 24, 2024
Via
Benzinga
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
September 24, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
September 20, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
Via
Benzinga
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
August 12, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
WVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
August 01, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 26, 2024
Via
Benzinga
What's Going On With Wave Life Sciences Stock On Tuesday?
June 25, 2024
Via
Benzinga
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
June 25, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
June 12, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
May 30, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.